Article
Chronic treatment with P2-purinergic receptor agonists induces phenotypic modulation of the HL-60 and U937 human myelogenous leukemia cell lines.
Journal of leukocyte biology - 1 Aug 1991
Cowen D S, Berger M, Nuttle L, Dubyak G R
Abstract excerpt
In previous studies we have demonstrated that extracellular ATP (and UTP), acting through P2-purinergic receptors, can stimulate the inositol phospholipid signaling system in neutrophils and monocytes, as well as in neutrophil/monocyte progenitor cells. In this study we have examined the ability of extracellular nucleotides to modulate the phenotype of myelomonocytic progenitor cells. As model systems, we...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
